American Portfolios Advisors’s Precision BioSciences DTIL Stock Holding History

American Portfolios Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$44.1K	Hold	1,131	–	–	﹤0.01%	1785
2022 Q2	$54.3K	Hold	1,131	–	–	﹤0.01%	1714
2022 Q1	$105K	Buy	1,131 +125	+12%	+$17K	﹤0.01%	1483
2021 Q4	$223K	Sell	1,006 -8	-0.8%	-$2.23K	0.01%	1099
2021 Q3	$351K	Hold	1,014	–	–	0.01%	874
2021 Q2	$381K	Buy	1,014 +8	+0.8%	+$2.4K	0.01%	839
2021 Q1	$312K	Hold	1,006	–	–	0.01%	846
2020 Q4	$252K	Hold	1,006	–	–	0.01%	806
2020 Q3	$186K	Hold	1,006	–	–	0.01%	823
2020 Q2	$251K	Sell	1,006 -167	-14%	-$36.6K	0.02%	670
2020 Q1	$212K	Sell	1,173 -166	-12%	-$43.5K	0.02%	628
2019 Q4	$558K	Buy	+1,339	New	+$421K	0.04%	393

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

American Portfolios Advisors's DTIL Position: Q3 2022 in Review

American Portfolios Advisors held its Precision BioSciences (DTIL) position steady in Q3 2022 at 1,131 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

American Portfolios Advisors first reported a position in DTIL in Q4 2019 and has held it in 12 quarters since. The position peaked at $558K in Q4 2019. 102 funds tracked by Wall St. Rank hold DTIL as of Q3 2022.

American Portfolios Advisors held 1,131 shares of Precision BioSciences worth $44.1K as of Q3 2022.
American Portfolios Advisors left its Precision BioSciences share count unchanged in Q3 2022.
Precision BioSciences made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1785 holding.
American Portfolios Advisors first reported a position in Precision BioSciences in Q4 2019 and has held it in 12 quarters since.
American Portfolios Advisors's Precision BioSciences position peaked at $558K in Q4 2019.
102 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.